157 related articles for article (PubMed ID: 8020153)
1. Growth suppression of transformed BALB/c 3T3 cells by transforming growth factor beta 1 occurs only in the presence of their normal counterparts.
Silingardi P; Klein JL; Mesnil M; Yamasaki H
Carcinogenesis; 1994 Jun; 15(6):1181-5. PubMed ID: 8020153
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation.
Hamel E; Katoh F; Mueller G; Birchmeier W; Yamasaki H
Cancer Res; 1988 May; 48(10):2832-6. PubMed ID: 3258789
[TBL] [Abstract][Full Text] [Related]
3. Association of viral oncogene-induced changes in gap junctional intercellular communication and morphological transformation in BALB/c3T3 cells.
Katoh F; Klein JL; Bignami M; Yamasaki H
Carcinogenesis; 1993 Mar; 14(3):435-40. PubMed ID: 8384090
[TBL] [Abstract][Full Text] [Related]
4. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
Longstreet M; Miller B; Howe PH
Oncogene; 1992 Aug; 7(8):1549-56. PubMed ID: 1630817
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
Serra R; Verderame MF; Isom HC
Cell Growth Differ; 1992 Oct; 3(10):693-704. PubMed ID: 1332741
[TBL] [Abstract][Full Text] [Related]
6. Growth suppression of transformed cells by a human placental extract not related to transforming growth factor beta.
Klein JL; Hamel E; Tayot JL; Yamasaki H
J Cancer Res Clin Oncol; 1991; 117(3):192-6. PubMed ID: 2033088
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta stimulates mitogenically mouse NIH3T3 fibroblasts and those cells transformed by the EJ-H ras oncogene.
Benzakour O; Merzak A; Dooghe Y; Pironin M; Lawrence D; Vigier P
Growth Factors; 1992; 6(4):265-75. PubMed ID: 1340206
[TBL] [Abstract][Full Text] [Related]
9. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid.
De Benedetti F; Falk L; Ruscetti FW; Colburn NH; Faltynek CR; Oppenheim JJ
Cancer Res; 1991 Feb; 51(4):1158-64. PubMed ID: 1847657
[TBL] [Abstract][Full Text] [Related]
10. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
11. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta induces an inhibitory effect of normal cells directed against transformed cells.
Höfler P; Wehrle I; Bauer G
Int J Cancer; 1993 Apr; 54(1):125-30. PubMed ID: 8478139
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.
Oft M; Peli J; Rudaz C; Schwarz H; Beug H; Reichmann E
Genes Dev; 1996 Oct; 10(19):2462-77. PubMed ID: 8843198
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta 1 suppresses transformation in hepatocytes by regulating alpha 1 beta 1 integrin expression.
Serra R; Carbonetto S; Lord M; Isom HC
Cell Growth Differ; 1994 May; 5(5):509-17. PubMed ID: 8049157
[TBL] [Abstract][Full Text] [Related]
15. Differential growth factor expression in transformed mouse NIH-3T3 cells.
Ciardiello F; Valverius EM; Colucci-D'Amato GL; Kim N; Bassin RH; Salomon DS
J Cell Biochem; 1990 Jan; 42(1):45-57. PubMed ID: 1967612
[TBL] [Abstract][Full Text] [Related]
16. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
[TBL] [Abstract][Full Text] [Related]
17. Loss of differentiation control in transformed 3T3 T proadipocytes.
Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenic potential and genomic instability of beryllium sulphate in BALB/c-3T3 cells.
Keshava N; Zhou G; Spruill M; Ensell M; Ong TM
Mol Cell Biochem; 2001 Jun; 222(1-2):69-76. PubMed ID: 11678613
[TBL] [Abstract][Full Text] [Related]
19. Response of normal and oncogene-transformed human mammary epithelial cells to transforming growth factor beta 1 (TGF-beta 1): lack of growth-inhibitory effect on cells expressing the simian virus 40 large-T antigen.
Basolo F; Fiore L; Ciardiello F; Calvo S; Fontanini G; Conaldi PG; Toniolo A
Int J Cancer; 1994 Mar; 56(5):736-42. PubMed ID: 8314352
[TBL] [Abstract][Full Text] [Related]
20. Permanent conversion of mouse and human cells transformed by activated ras or raf genes to apparently normal cells by treatment with the antibiotic azatyrosine.
Shindo-Okada N; Makabe O; Nagahara H; Nishimura S
Mol Carcinog; 1989; 2(3):159-67. PubMed ID: 2675904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
